Show simple item record

Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma.

dc.contributor.authorHelgadottir, H
dc.contributor.authorKis, L
dc.contributor.authorLjungman, P
dc.contributor.authorLarkin, J
dc.contributor.authorKefford, R
dc.contributor.authorAscierto, PA
dc.contributor.authorHansson, J
dc.contributor.authorMasucci, G
dc.date.accessioned2017-05-08T09:29:00Z
dc.date.issued2017-07
dc.identifier.citationAnnals of oncology : official journal of the European Society for Medical Oncology, 2017, 28 (7), pp. 1672 - 1673
dc.identifier.issn0923-7534
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/637
dc.identifier.eissn1569-8041
dc.identifier.doi10.1093/annonc/mdx177
dc.formatPrint
dc.format.extent1672 - 1673
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectHumans
dc.subjectMelanoma
dc.subjectNeoplasm Metastasis
dc.subjectAnemia, Aplastic
dc.subjectAntineoplastic Combined Chemotherapy Protocols
dc.subjectAntibodies, Monoclonal
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectCTLA-4 Antigen
dc.subjectProgrammed Cell Death 1 Receptor
dc.subjectIpilimumab
dc.subjectNivolumab
dc.titleLethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma.
dc.typeJournal Article
rioxxterms.versionofrecord10.1093/annonc/mdx177
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2017-07
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfAnnals of oncology : official journal of the European Society for Medical Oncology
pubs.issue7
pubs.notes12 months
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer/Melanoma and Kidney Cancer (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer/Melanoma and Kidney Cancer (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume28
pubs.embargo.terms12 months
icr.researchteamMelanoma and Kidney Canceren_US
dc.contributor.icrauthorLarkin, Jamesen
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail
Name:
JL_mdx177.pdf
Size:
717.1Kb
Format:
PDF
Description:
Accepted version
View/Open

This item appears in the following collection(s)

Show simple item record